Drug Profile
Filaminast
Alternative Names: PDA 641; WAY 123641; WAY PDA 641Latest Information Update: 26 Oct 1999
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antiasthmatics; Heart failure therapies; Small molecules
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 26 Oct 1999 Discontinued-II for Asthma in European Union (PO)
- 26 Oct 1999 Discontinued-II for Asthma in USA (PO)
- 23 May 1997 Phase-II clinical trials for Asthma in European Union (PO)